SCHEMBL98444

SCHEMBL98444

C=CCC(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
DGAT1 O75907 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP2D6 P10635 1/20 0.33
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
CA12 O43570 1/20 0.32
CA2 P00918 1/20 0.32
CA14 Q9ULX7 1/20 0.32
HTT P42858 1/20 0.31
GSTO1 P78417 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8523298 0.83 DGAT1 (0.33) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL18801577 0.82 ALDH1A1 (0.31) ALDH1A1LMNA
SCHEMBL8462922 0.80 TSHR (0.32) ALDH1A1THRBTSHRTDP1
SCHEMBL16205893 0.80 ALDH1A1 (0.31) SMN1; SMN2ALDH1A1HIF1A
SCHEMBL17460816 0.80 HDAC3 (0.34) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL28514999 0.78 HDAC3 (0.33) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL8868668 0.78 HDAC6 (0.37) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL27403835 0.78 HDAC6 (0.37) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL27945867 0.78 HTT (0.32) HTT
SCHEMBL2740502 0.78 HDAC6 (0.37) HDAC3HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117088786-A Eptification intermediate and preparation method thereof 上海医药工业研究院有限公司 2023-11-21 CN claimed
CN-111019225-B Anti-static anti-fouling plastic film for packaging 浙江保禄包装科技股份有限公司 2022-04-15 CN claimed
CN-109415513-B Silicon-rich silsesquioxane resins 美国陶氏有机硅公司 2022-02-25 CN claimed
CN-113152086-A Antibacterial moisture-absorption breathable fabric 刘利红 2021-07-23 CN claimed
CN-112981956-A Moisture-absorbing breathable jean fabric 张霞 2021-06-18 CN claimed
CN-111019225-A Anti-static anti-fouling plastic film for packaging 田朝义 2020-04-17 CN claimed
CN-110515271-A A kind of photosensitive polymer combination and its application HANGZHOU FIRST APPLIED MAT CO LTD 2019-11-29 CN claimed
US-20190211155-A1 SILICON-RICH SILSESQUIOXANE RESINS DOW SILICONES CORPORATION 2019-07-11 US claimed
CN-109913195-A A kind of package acid improving acid fracturing EFFECTIVE RANGE 西南石油大学 2019-06-21 CN claimed
CN-109415513-A Silsesquioxane resins rich in silicon 美国陶氏有机硅公司 2019-03-01 CN claimed
CN-100427518-C Flame-proof acrylic resin for reflecting cloth NANJING YESHILI FINE CHEMICAL (CN) 2008-10-22 CN claimed
EP-4029868-B1 MCL-1 INHIBITORS GILEAD SCIENCES INC (US) 2026-05-20 EP disclosed
US-20260116891-A1 Oxazepin Derivative TEIJIN PHARMA LTD (JP) 2026-04-30 US disclosed
US-20260115296-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES UNIV YALE (US) 2026-04-30 US disclosed
EP-3886904-B1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2026-04-22 EP disclosed
CN-88100500-A NOVEL POLYAMINE DERIVATIVES 1988-09-07 CN disclosed
EP-0169176-A1 Tert-butyl gamma dimethylamino beta-hydroxy butyrate and process for its preparation Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1986-01-22 EP disclosed
US-4414153-A 1,3-Dithietane-2-carboxylic acid penicillin and cephalosporin derivatives YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1983-11-08 US disclosed
US-4198339-A INTERMEDIATES FOR PENICILLINS AND CEPHALOSPORINS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1980-04-15 US disclosed
US-3946054-A PERFUMES, TOBACCO, FOOD FLAVORS INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1976-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260115296-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES CRBN, VHL, ADRM1 HDAC3 3022/4885HDAC1 2489/4885HDAC2 3533/4885
US-20260116891-A1 Oxazepin Derivative HCRTR2, HCRTR1, OXTR HDAC3 326/4885HDAC1 574/4885HDAC2 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.